Source: DGNews | Posted 8 years ago
Higher Dose/Frequency Rebif (Interferon beta-1a) Provides Significant Reduction in Frequency of Multiple Sclerosis Relapses In Patients Who Convert From Avonex
Tags:
New data presented today at the 13th Meeting of the European Neurological Society
GENEVA, SWITZERLAND, ROCKLAND, MA, and NEW YORK, NY -- June 18, 2003 -- Patients who converted from Avonex
Comments